RAYMOND JAMES & ASSOCIATES – AstraZeneca PLC Transaction History
RAYMOND JAMES & ASSOCIATES portfolio value:
$139.24M
portfolio value
RAYMOND JAMES & ASSOCIATES quarter portfolio value change:
-17.00%
quarter
AstraZeneca PLC 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +3.22% | 79.09K shares | -23.28M | $54.84 | 2.53M |
| Q2 2022 | share | Increase | +5.00% | 117.17K shares | 7.10M | $66.07 | 2.46M |
| Q1 2022 | share | Increase | +9.64% | 205.97K shares | 30.95M | $66.34 | 2.34M |
| Q4 2021 | share | Decrease | -1.69% | -36.66K shares | -6.07M | $58.47 | 2.13M |
| Q3 2021 | share | Increase | +46.56% | 690.49K shares | 41.70M | $60.06 | 2.17M |
| Q2 2021 | share | Increase | +8.17% | 111.96K shares | 20.66M | $59.44 | 1.48M |
| Q1 2021 | share | Increase | +22.38% | 250.77K shares | 12.16M | $49.34 | 1.37M |
| Q4 2020 | share | Decrease | -11.39% | -144.02K shares | -13.28M | $48.68 | 1.12M |
| Q3 2020 | share | Decrease | -7.05% | -95.83K shares | -2.65M | $53.37 | 1.26M |
| Q2 2020 | share | Increase | +6.72% | 85.62K shares | 15.01M | $51.1 | 1.36M |
| Q1 2020 | share | Increase | +5.37% | 65.01K shares | -3.38M | $43.15 | 1.27M |
| Q4 2019 | share | Increase | +0.59% | 7.05K shares | 6.71M | $47.17 | 1.20M |
| Q3 2019 | share | Decrease | -5.77% | -73.64K shares | 916K | $42.17 | 1.20M |
| Q2 2019 | share | Decrease | -11.47% | -165.33K shares | -5.6M | $38.66 | 1.27M |
| Q1 2019 | share | Decrease | -45.01% | -1.18M shares | -41.28M | $37.87 | 1.44M |
| Q4 2018 | share | Decrease | -11.43% | -338.46K shares | -17.56M | $34.78 | 2.62M |
| Q3 2018 | share | Decrease | -16.63% | -590.64K shares | -7.53M | $36.23 | 2.95M |
| Q3 2018 | call | Decrease | -100.00% | -18.5K shares | -1K | $36.23 | 0 |
| Q2 2018 | call | 0.00% | 0 shares | 0 | $31.79 | 18.5K | |
| Q2 2018 | share | Decrease | -8.42% | -326.59K shares | -10.92M | $31.79 | 3.55M |
| Q1 2018 | share | Decrease | -9.63% | -413.12K shares | -13.28M | $31.66 | 3.87M |
| Q1 2018 | call | Increase | +0.54% | 100 shares | 0 | $31.66 | 18.5K |
| Q4 2017 | share | Increase | +4.23% | 174.03K shares | 9.41M | $30.56 | 4.29M |
| Q4 2017 | call | 0.00% | 0 shares | -1K | $30.56 | 18.4K | |
| Q3 2017 | share | Increase | +12.66% | 462.53K shares | 14.90M | $29.84 | 4.11M |
| Q3 2017 | call | 0.00% | 0 shares | -21K | $29.84 | 18.4K | |
| Q2 2017 | call | 0.00% | 0 shares | 12K | $29.58 | 18.4K | |
| Q2 2017 | share | Increase | +2.31% | 82.33K shares | 13.34M | $29.58 | 3.65M |
| Q1 2017 | share | Increase | +46.35% | 1.13M shares | 44.54M | $27.02 | 3.57M |
| Q1 2017 | call | Increase | 0.00% | 18.4K shares | 11K | $27.02 | 18.4K |
| Q4 2016 | share | Decrease | -8.57% | -228.74K shares | -21.03M | $22.97 | 2.44M |
| Q3 2016 | share | Increase | +111.53% | 1.40M shares | 49.61M | $27.63 | 2.66M |
| Q2 2016 | share | Increase | +9.04% | 104.63K shares | 5.50M | $25.05 | 1.26M |
| Q1 2016 | share | Increase | +3.65% | 40.78K shares | -5.31M | $23.37 | 1.15M |